DDO-3055
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
June 14, 2022
A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease
(clinicaltrials.gov)
- P1 | N=54 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Recruiting ➔ Completed
Trial completion • Chronic Kidney Disease • Nephrology • Renal Disease
June 08, 2022
Food Effect Study of DDO-3055 Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=14 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Completed
Trial completion • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
October 26, 2021
Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.
(clinicaltrials.gov)
- P1; N=30; Enrolling by invitation; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Not yet recruiting ➔ Enrolling by invitation; Trial completion date: Mar 2021 ➔ Dec 2021; Trial primary completion date: Feb 2021 ➔ Dec 2021
Clinical • Enrollment open • Trial completion date • Trial primary completion date • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
March 01, 2021
Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects.
(clinicaltrials.gov)
- P1; N=36; Not yet recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Clinical • New P1 trial • Anemia • Hematological Disorders • VEGFA
July 14, 2020
Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.
(clinicaltrials.gov)
- P1; N=30; Not yet recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Clinical • New P1 trial • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
December 13, 2019
Food Effect Study of DDO-3055 Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1; N=14; Not yet recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Clinical • New P1 trial
1 to 6
Of
6
Go to page
1